Jane Street’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $765K | Buy |
57,281
+10,336
| +22% | +$138K | ﹤0.01% | 3183 |
|
|
2025
Q1 | $478K | Sell |
46,945
-54,167
| -54% | -$552K | ﹤0.01% | 3979 |
|
|
2024
Q4 | $1.6M | Buy |
101,112
+40,934
| +68% | +$648K | ﹤0.01% | 2367 |
|
|
2024
Q3 | $3.49M | Buy |
60,178
+15,281
| +34% | +$887K | ﹤0.01% | 1718 |
|
|
2024
Q2 | $2.05M | Buy |
44,897
+25,518
| +132% | +$1.17M | ﹤0.01% | 2698 |
|
|
2024
Q1 | $1.28M | Sell |
19,379
-38
| -0.2% | -$2.52K | ﹤0.01% | 2885 |
|
|
2023
Q4 | $772K | Buy |
19,417
+8,811
| +83% | +$350K | ﹤0.01% | 3634 |
|
|
2023
Q3 | $338K | Sell |
10,606
-1,960
| -16% | -$62.5K | ﹤0.01% | 3968 |
|
|
2023
Q2 | $505K | Sell |
12,566
-6,476
| -34% | -$260K | ﹤0.01% | 3751 |
|
|
2023
Q1 | $813K | Buy |
+19,042
| New | +$813K | ﹤0.01% | 3086 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5905 |
|
|
2022
Q3 | – | Sell |
-33,356
| Closed | -$921K | – | 6063 |
|
|
2022
Q2 | $921K | Buy |
+33,356
| New | +$921K | ﹤0.01% | 2866 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5963 |
|
|
2020
Q3 | – | Sell |
-10,397
| Closed | -$390K | – | 4134 |
|
|
2020
Q2 | $390K | Buy |
+10,397
| New | +$390K | ﹤0.01% | 2777 |
|